US Patent Issued to PHILOCHEM on Sept. 29 for "Fibroblast activation protein ligands for targeted delivery applications" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,224, issued on Sept. 29, was assigned to PHILOCHEM AG (Otelfingen, Switzerland).

"Fibroblast activation protein ligands for targeted delivery applications" was invented by Ilaria Biancofiore (Otelfingen, Switzerland), Samuele Cazzamalli (Otelfingen, Switzerland), Sheila Plaza Dakhel (Otelfingen, Switzerland), Etienne J. Donckele (Otelfingen, Switzerland), Jacopo Millul (Otelfingen, Switzerland), Florent Samain (Otelfingen, Switzerland) and Eleonore Schmidt (Otelfingen, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads...